Parental occupational exposures and the risk of childhood sporadic retinoblastoma: a report from the Children's Oncology Group

被引:8
|
作者
Omidakhsh, Negar [1 ]
Bunin, Greta R. [2 ,3 ]
Ganguly, Arupa [4 ]
Ritz, Beate [1 ]
Kennedy, Nola [5 ]
von Ehrenstein, Ondine S. [1 ,6 ]
Krause, Niklas [1 ,7 ]
Heck, Julia E. [1 ]
机构
[1] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Epidemiol, Los Angeles, CA 90095 USA
[2] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA
[4] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA
[5] Calif State Univ Northridge, Dept Environm & Occupat Hlth, Northridge, CA 91330 USA
[6] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA USA
[7] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Environm Hlth Sci, Los Angeles, CA USA
关键词
retinoblastoma; childhood cancer; RADIATION-EXPOSURE; CANCER-RISK; AGE; MUTATION; COHORT; AGRICULTURE; PREGNANCY; SURVIVORS; SWEDEN;
D O I
10.1136/oemed-2017-104404
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives We examined associations between parental occupational chemical exposures up to 10 years before conception and the risk of sporadic retinoblastoma among offspring. Methods In our multicentre study on non-familial retinoblastoma, parents of 187 unilateral and 95 bilateral cases and 155 friend controls were interviewed by telephone. Exposure information was collected retroactively through a detailed occupational questionnaire that asked fathers to report every job held in the 10 years before conception, and mothers 1month before and during the index pregnancy. An industrial hygienist reviewed all occupational data and assigned an overall exposure score to each job indicating the presence of nine hazardous agents. Results We estimated elevated ORs for unilateral and bilateral retinoblastoma among offspring of fathers who were exposed to polycyclic aromatic hydrocarbons or paints in the 10 years before conception. However, only for exposure to paints did confidence limits exclude the null for bilateral disease (OR: 8.76, 95%CI: 1.32 to 58.09). Maternal prenatal exposure to at least one of the nine agents was related to increased risk of unilateral disease in their children (OR: 5.25, 95%CI: 1.14 to 24.16). Fathers exposed to at least one of the nine agents and who were 30 years of age were at increased risk of having a child diagnosed with bilateral retinoblastoma (OR: 6.59, 95%CI: 1.34 to 32.42). Conclusions Our results suggest a role for several hazardous occupational exposures in the development of childhood retinoblastoma.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 50 条
  • [21] Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children’s Oncology Group
    Philip J. Lupo
    Heather E. Danysh
    Stephen X. Skapek
    Douglas S. Hawkins
    Logan G. Spector
    Renke Zhou
    M. Fatih Okcu
    Karin Papworth
    Erik B. Erhardt
    Seymour Grufferman
    Cancer Causes & Control, 2014, 25 : 905 - 913
  • [22] Maternal and birth characteristics and childhood rhabdomyosarcoma: a report from the Children's Oncology Group
    Lupo, Philip J.
    Danysh, Heather E.
    Skapek, Stephen X.
    Hawkins, Douglas S.
    Spector, Logan G.
    Zhou, Renke
    Okcu, M. Fatih
    Papworth, Karin
    Erhardt, Erik B.
    Grufferman, Seymour
    CANCER CAUSES & CONTROL, 2014, 25 (07) : 905 - 913
  • [23] Transition practices for survivors of childhood cancer: a report from the Children’s Oncology Group
    Jordan Gilleland Marchak
    Karim T. Sadak
    Karen E. Effinger
    Regine Haardörfer
    Cam Escoffery
    Karen E. Kinahan
    David R. Freyer
    Eric J. Chow
    Ann Mertens
    Journal of Cancer Survivorship, 2023, 17 : 342 - 350
  • [24] Barriers to the Enrollment of Children in the Children's Oncology Group Study of Very Low Risk Wilms Tumor: A Report from the Children's Oncology Group
    Fernandez, Conrad V.
    Li, Ning
    Mullen, Elizabeth A.
    Grundy, Paul E.
    Perman, Elizabeth J.
    Shamberger, Robert C.
    Ehrlich, Peter F.
    Dome, Jeffrey S.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2011, 33 (07) : 521 - 523
  • [25] Endocrine late effects of childhood cancer therapy:: A report from the children's oncology group
    Nandagopal, Radha
    Laverdiere, Caroline
    Mulrooney, Daniel
    Hudson, Melissa M.
    Meacham, Lillian
    HORMONE RESEARCH, 2008, 69 (02) : 65 - 74
  • [26] Ethnicity and survival in childhood acute myeloid leukemia: a report from the Children's Oncology Group
    Aplenc, R
    Alonzo, TA
    Gerbing, RB
    Smith, FO
    Meshinchi, S
    Ross, JA
    Perentesis, J
    Woods, WG
    Lange, BJ
    Davies, SM
    BLOOD, 2006, 108 (01) : 74 - 80
  • [27] Auditory Late Effects of Childhood Cancer Therapy: A Report From the Children's Oncology Group
    Grewal, Satkiran
    Merchant, Thomas
    Reymond, Renee
    McInerney, Maryrose
    Hodge, Cathy
    Shearer, Patricia
    PEDIATRICS, 2010, 125 (04) : E938 - E950
  • [28] Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group
    Friedman, Debra L.
    Krailo, Mark
    Villaluna, Doojduen
    Gombos, Dan
    Langholz, Bryan
    Jubran, Rima
    Shields, Carol
    Murphree, Linn
    O'Brien, Joan
    Kessel, Sandra
    Rodriguez-Galindo, Carlos
    Chintagumpala, Murali
    Meadows, Anna T.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (07)
  • [29] Cesarean Delivery and Risk of Infant Leukemia: A Report from the Children's Oncology Group
    Marcotte, Erin L.
    Richardson, Michaela R.
    Roesler, Michelle A.
    Spector, Logan G.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2018, 27 (04) : 473 - 478
  • [30] RISK OF SEPSIS DURING BLINATUMOMAB ADMINISTRATION: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
    Thompson, Joel
    Elgarten, Caitlin
    Withycombe, Janice
    Kairalla, John
    Wang, Cindy
    Zupanec, Susan
    Gupta, Sumit
    Rau, Rachel
    Rabin, Karen
    Loh, Mignon
    Raetz, Elizabeth
    Alexander, Sarah
    Miller, Tamara
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S10 - S10